Apoptosis and bcl-2 expression in irradiated lungs and the effect of pentoxifylline

Acta Medica (Hradec Kralove). 2001;44(4):125-30.

Abstract

We measured number of bcl-2, apoptotic, neutrophil, and surfactant apoprotein D (SP-D) positive cells in irradiated rat lungs during different time points after the sublethal whole-thorax irradiation of rats. We also investigated the influence of pentoxifylline (PTX) therapy on these markers. Wistar rats were given 15 Gy thoracic irradiation and PTX (35 mg/kg) twice a week. Animals were examined histologically and imunohistochemically at intervals from 1-12 weeks. In non-treated rats compared with treated rats, bcl-2 expression was significantly inhibited from 4 weeks after irradiation. A higher apoptosis presence in non-treated rats from 4 weeks was found and apoptosis development in PTX-treated animals was delayed and started 8 weeks after irradiation. Similar differences were measured during neutrophil granulocytes examination. Neutrophil penetration in non-treated rats was found 5 weeks after irradiation in contrast to the RP onset of PTX-treated animals 8 weeks after irradiation. The number of SP-D positive cells in non-treated rats observed until 5 weeks after irradiation was higher than in the control group. PTX-treated animals expressed higher number of SP-D positive cells during the whole experiment than the control group. We suggest that apoptosis is linked to neutrophil granulocyte actions during the RP onset and that PTX-therapy causes diminished inflammation development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / radiation effects*
  • Glycoproteins / metabolism
  • Immunohistochemistry
  • Lung / metabolism
  • Lung / pathology
  • Lung / radiation effects*
  • Male
  • Neutrophils / pathology
  • Pentoxifylline / pharmacology*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Pulmonary Surfactant-Associated Protein D
  • Pulmonary Surfactants / metabolism
  • Radiation Pneumonitis / drug therapy
  • Radiation Pneumonitis / metabolism
  • Radiation Pneumonitis / pathology
  • Radiation-Protective Agents / pharmacology*
  • Rats
  • Rats, Wistar

Substances

  • Glycoproteins
  • Proto-Oncogene Proteins c-bcl-2
  • Pulmonary Surfactant-Associated Protein D
  • Pulmonary Surfactants
  • Radiation-Protective Agents
  • Pentoxifylline